Click here to load this Caspio Online Database.
Log Out

U.S. Surgeon General Recommended!

     The recent report endorsed by the U.S. Surgeon General sites the comprehensive systematic review of 298 research studies confirming that a clinical pharmacist directed disease management program return on investment is between 5.5 and 16.7 greater than cost. The overall average based on two decades of data was $10.7 per $1 of allocated cost.